yum cha 飲 茶 · 2014. 8. 28. · 5 earnings projection sources: company, cgihk research...
TRANSCRIPT
1
Yum Cha 飲 茶 August 28, 2014
TALKING POINTS
CHART OF THE DAY—BACK TO PLAN A; BOOSTING INFRASTRUCTURE
Analyst: John Mulcahy, Managing Director
Source: Bloomberg
INDICES Closing DoD%
Hang Seng Index 24,918.8 (0.6)
HSCEI 11,074.3 (0.4)
Shanghai COMP 2,209.5 0.1
Shenzhen COMP 1,209.2 0.6
Gold 1,284.2 0.1
BDIY 1,063.0 (0.7)
Crude Oil, WTI(US$/BBL) 93.7 (0.1)
Crude Oil, BRENT(US$/BBL) 102.7 0.2
HIBOR, 3-M 0.4 (0.6)
SHIBOR, 3-M 4.7 (0.0)
RMB/USD 6.1 (0.2)
DAILY NOTES FOR THIS WEEK
Aug 28 Leading Index
Aug 31 Manufacturing PMI
Aug 31 HSBC Manufacturing PMI
ANTON OILFIELD SERVICES GROUP [3337.HK] - Anton’s 1H14 core net profit came in at
only RMB27m, plummeting by 82% year-on-year (YoY), 73% below our estimate. The operating
deleveraging is more severe than expected, with EBIT margin in 1H14 dropping 5.7ppt to 15.2%
from 20.9% in 1H13. We believe weak domestic demand will continue in the foreseeable future,
which will continue to put significant pressure on Anton. We have trimmed our 2014E/2015E
earnings forecasts by 33%. We cut our target price (TP) to HK$2.60 from HK$3.90 (unchanged
20x 2014E PER, average multiple since listing). Reiterate SELL.
MODERN BEAUTY SALON HOLDINGS [0919.HK; HK$0.59; Not Rated] - We recently visited
this micro-cap, a market leader in the Hong Kong beauty sector, offering high-quality facial and
body treatments with natural ingredients. The company operates 82 stores or a total of 214
service points including Hong Kong, China, Malaysia Singapore, and Taiwan, with 500,000
customers engaged in their beauty services, including 350,000 in Hong Kong. The company has
expansion ambitions, and aims to add 50 stores in China, mainly in Tier 2 & 3 cities, in the next
two years, from 10 now. It has also entered a joint venture agreement with the Australian
manufacturer and distributor of Advanced Natural®, a supplier to Modern, and which the parties
aim to list in due course. Modern has recovered from the crisis in Hong Kong’s beauty care
sector in 2012, and is restoring operating margins after a poor year in FY 2013.
China’s macro picture is beginning to look like the pattern of the previous government, which
repeatedly used public expenditure to boost growth when manufacturing or services slowed.
The monetary stimulus provided during Q2 has come to an end, with the People’s Bank of
China reluctant to build on the existing credit problem, and with the real estate sector sluggish
at best, the remaining avenue for maintaining the growth target (“about” 7.5% GDP expansion)
is infrastructure. Increased rail investment is the main impetus behind the current infrastructure
boost, and there have been various less direct measures including tax reductions for small
companies and incentives for banks to lend to small & medium enterprises (SMEs) and to rural
borrowers. As the chart shows, growth in manufacturing and real investment have slowed this
year, and after reducing the pace of infrastructure investment in 2013 the central government
has again been using this tool. Data due in the next few days is likely to show that manufactur-
ing is slowing again, and the property market has been weakening for some time.
Source: Bloomberg
2
Anton Oilfield Services Group [3337.HK]
Anton’s 1H14 core net profit came in at only RMB27m, plummeting by 82% year-on-year (YoY), 73% below our estimate. The operating deleveraging is more se-vere than expected, with EBIT margin in 1H14 dropping 5.7ppt to 15.2% from 20.9% in 1H13. Both net finance expenses (+317% YoY) and the effective tax rate (57%) are higher than our expectation. We believe weak domestic demand will continue in the foreseeable future, which will continue to put significant pres-sure on Anton. We have trimmed our 2014E/2015E earnings forecasts by 33%. We cut our target price (TP) to HK$2.60 from HK$3.90 (unchanged 20x 2014E PER, average multiple since listing). Reiterate SELL.
1H14 Results highlights. Total revenue increased by 5% YoY to
RMB1,112m. Revenue from China (72% of total) dropped 4% YoY as a re-sult of the general weakness in the domestic market. Overseas revenue jumped 42% YoY, helped by 41% YoY growth in the Middle East revenue. EBIT margin in 1H14 dropped 5.7ppt YoY to 15.2%. While pre-tax profit de-clined by 64% YoY, income tax increased by 15% YoY (effective tax rate therefore reached 57%). This resulted in an 82% YoY decline in core net profit. As of end-June, trade receivables increased by 19% to RMB1.55bn from RMB1.30bn as of Dec 2013. Anton reported RMB434m operating cash outflow in 1H14, which is quite significant in our view. As of end-June, net debt/equity ratio reached 57% (up from 24% as of end-2013).
Weakness in Sichuan and Ordos Basin; Steady growth in Tarim Basin.
Revenue from Tarim Basin increased by 15% YoY to RMB360m (45% of China total) as Anton introduced new products lines there. However, revenue from Sichuan dropped 62% YoY to only RMB45m, due to the change in Chi-na major oil companies’ operating plans. In Ordos Basin, revenue increased by only 7.5% YoY (significant slowdown from 37% YoY growth in 2H13) as a result of reduced demand for fracking services.
Upside risks: (1) Strong order flow; (2) faster-than-expected shale gas de-
velopment; (3) potential increase in shareholding by Schlumberger.
Wayne Fung, CFA —Analyst
(852) 3698-6319
John Mulcahy—Head of Research
(852) 3698-6889
Oilfield Services Sector
Operating deleverage; Tough time likely to last; Reiterate SELL
SELL (Unchanged)
Close: HK$3.98 (Aug 27, 2014)
Target Price: HK$2.60 (-35%)
Share Price Performance
Market Cap US$1,136m
Shares Outstanding 2,192m
Auditor PWC
Free Float 49.4%
52W range HK$3.91-6.20
3M average daily T/O US$4.3m
Major Shareholding LUO Lin (30.9%)
(Chairman and CEO)
Schlumberger
(19.7%)
August 28, 2014
Results review
1H13 1H14 Chg (YoY)
Revenue 1,057 1,112 5.2%
Other gains 12 3 -76.4%
Operating expenses (835) (946) 13.3%
EBIT 234 169 -27.8%
EBITDA 294 261 -11.4%
Interest income 1 11 1412.1%
Finance expenses (22) (100) 355.3%
Share of profit/(loss) of JCE (6) (5) -11.2%
Impairment loss of LT investment in JCE 0 0 n/a
Pretax profit 207 75 -63.8%
Income tax exp (37) (43) 15.3%
After tax profit 170 32 -81.2%
NI (5) (5) -14.7%
Net profit 164 27 -83.4%
Recurring net profit 151 27 -81.9%
Sources: Company, CGIHK Research
3
Figure 1: Revenue Breakdown by Region (1H14)
Sources: Company, CGIHK Research
North China29%
Northwest China32%
Northeast China and
others7%
Southwest China
4%
The Middle East21%
Central Asia3%
Africa1%
America3%
0
1
2
3
4
5
6
7
8
9
Dec-07
Mar-08
Jun-08
Oct-08
Jan-09
Apr-09
Jul-09
Nov-09
Feb-10
May-10
Aug-10
Dec-10
Mar-11
Jun-11
Sep-11
Jan-12
Apr-12
Jul-12
Oct-12
Feb-13
May-13
Aug-13
Nov-13
Mar-14
Jun-14
HKD
37x
29x
21x
13x
5x
Figure 2: PER Band
Sources: Bloomberg, CGIHK Research estimates
4
Figure 3: Segment Forecasts
Sources: Company, CGIHK Research estimates
(RMB m) 2008 2009 2010 2011 2012 2013 2014E 2015E
Down-hole operation
Revenue 112 100 344 570 857 1,082 1,162 1,292
Operating cost (47) (62) (205) (312) (386) (494) (535) (594)
EBITDA 64 38 139 259 471 588 628 698
EBITDA margin 57.7% 37.8% 40.4% 45.4% 55.0% 54.4% 54.0% 54.0%
Well completion
Revenue 241 214 325 320 458 548 671 738
Operating cost (87) (122) (185) (210) (312) (350) (470) (517)
EBITDA 154 92 140 110 146 198 201 222
EBITDA margin 63.9% 42.8% 43.1% 34.3% 31.8% 36.1% 30.0% 30.0%
Drilling technology
Revenue 70 88 97 198 433 589 771 893
Operating cost (43) (66) (63) (152) (325) (453) (593) (687)
EBITDA 28 22 34 45 108 136 177 205
EBITDA margin 39.3% 25.4% 35.3% 23.0% 24.9% 23.1% 23.0% 23.0%
Tubular services
Revenue 341 288 184 171 257 315 313 359
Operating cost (249) (237) (125) (131) (151) (165) (163) (187)
EBITDA 92 51 59 40 105 150 150 172
EBITDA margin 26.9% 17.8% 32.3% 23.5% 41.0% 47.5% 48.0% 48.0%
5
Earnings Projection
Sources: Company, CGIHK Research estimates
(RMB m) 2012 2013 2014E 2015E (RMB m) 2012 2013 2014E 2015E
Income statement (Y/E Dec) Cash flow statement (Y/E Dec)
Revenue 2,005 2,534 2,918 3,282 Pretax profit 367 490 300 343
Other gains 11 20 10 11 Depreciation 73 122 173 197
Operating expenses (1,617) (1,981) (2,458) (2,772) Amortization 21 16 16 16
EBIT 398 572 469 521 Share of results of JCE 0 10 0 (4)
D&A (93) (138) (189) (214) Net exchange loss 2 3 0 0
EBITDA 491 710 658 735 Change in working capital (133) (191) (76) (198)
Interest income 2 1 19 5 Income tax paid (49) (71) (66) (62)
Finance expenses (33) (74) (188) (187) Others 69 (0) 0 (0)
Share of profit/(loss) of JCE 0 (10) 0 4 Operating cash flow 350 379 348 293
Impairment loss of LT investment in JCE 0 0 0 0
Pretax profit 367 490 300 343 Purchase/(disposal) of PP&E (230) (813) (750) (350)
Income tax exp (50) (87) (66) (62) Purchase of land use right (21) 0 0 0
After tax profit 318 403 234 282 Purchase of intangible assets (22) (23) 0 0
NI (15) (21) (11) (11) Acquisition of subsidiaries 3 0 0 0
Net profit 303 383 224 270 Investment in JCE 0 (22) (30) (30)
Recurring net profit 303 369 224 270 Dividend received from JCE 0 0 0 0
Reported EPS (RMB) 0.14 0.18 0.10 0.13 Others (3) 49 0 0
Recurring EPS (RMB) 0.14 0.17 0.10 0.13 Investing cash flow (273) (809) (780) (380)
DPS (RMB) 0.05 0.06 0.03 0.04
Proceed from/(repayment of) borrowings 23 1,807 80 0
Proceed from equity/(share repurchase) 0 (18) 0 0
(RMB m) 2012 2013 2014E 2015E Dividend paid (47) (113) (120) (67)
Balance sheet (as of end-Dec) Others 13 18 0 0
Non current assets Financing cash flow (11) 1,695 (40) (67)
Property, plant and equipment 955 1,602 2,179 2,331
Land use rights 29 22 22 22 Net change in cash 65 1,265 (472) (154)
Intangible assets 371 375 359 343
Investment in JCE 4 17 47 81
Others 20 85 85 85 2012 2013 2014E 2015E
Total non current assets 1,379 2,101 2,692 2,863 Valuation
PER (recurring earnings) (x) 23 19 31 25
Current assets Dividend yield 1.4% 1.8% 1.0% 1.2%
Inventories 487 541 519 643 PBR (x) 3.5 3.0 2.9 2.6
Trade receivables 919 1,307 1,219 1,622 EV/EBITDA (x) 19 13 14 13
Note receivables 29 25 25 25 Growth rate
Prepayments and other receivables 240 191 334 257 Revenue 59% 26% 15% 12%
Restricted bank deposits 16 32 32 32 EBIT 128% 44% -18% 11%
Term deposits 0 0 0 0 EBITDA 110% 44% -7% 12%
Cash 523 1,770 1,298 1,144 Recurring net profit 177% 22% -39% 21%
Others 0 0 0 0 Recurring EPS 175% 20% -40% 21%
Total current assets 2,214 3,867 3,428 3,724 Operating ratios
EBIT margin 20% 23% 16% 16%
Total assets 3,593 5,968 6,120 6,586 EBITDA margin 25% 28% 23% 22%
Recurring net margin 15% 15% 8% 8%
Asset turnover (x) 1.7 1.5 1.2 1.2
Non current liabilities Adjusted ROE 17% 17% 10% 11%
Long term bonds 299 1,983 1,983 1,983 Adjusted ROA 10% 8% 4% 4%
Other long term payables 3 0 0 0 Interest coverage (x) 16.0 9.8 3.9 4.0
Deferred income tax liabilities 1 2 2 2 Net debt/equity Net cash 24% 45% 48%
Total non current liabilities 303 1,984 1,984 1,984 Current ratio (x) 1.8 2.4 2.1 2.0
Quick ratio (x) 1.4 1.3 1.3 1.4
Current liabilities Days inventories 160 194 170 170
Short term borrowings 223 399 479 479 Days receivables 143 160 158 158
Trade payables 693 578 918 722 Days payables 192 240 240 240
Notes payables 37 125 125 125
Accruals and other payables 218 449 67 515
Current income tax liabilties 37 56 56 56
Others 0 0 0 0
Total current liabilities 1,209 1,608 1,646 1,898
Equity
Share capital 201 203 203 203
Reserves 1,771 2,080 2,183 2,387
1,972 2,283 2,386 2,590
MI 109 93 103 114
Total equity 2,081 2,375 2,490 2,704
Total equity and liabilities 3,593 5,968 6,120 6,586
BVPS (RMB) 0.92 1.06 1.11 1.20
6
FINGER ON THE PULSE—VISIT NOTE
Analyst: Samuel Chan, CFA
Modern Beauty Salon Holdings [0919.HK; HK$0.59; Not Rated] - Financial Health Back On Track, New Expansion Plan In Sight
Market Cap: US$67m; Free Float: 25.9%
The Company. Listed in 2006, Modern Beauty is a market leader
in the Hong Kong beauty sector, offering high-quality facial and
body treatments with natural ingredients. Within Asia, the company
operates 82 stores or a total of 214 service points including Hong
Kong, China, Malaysia Singapore, and Taiwan, with 500,000
customers engaged in their beauty services, including 350,000 in
Hong Kong. The company also carries several self-owned brands
including Advanced Natural®, be®, p.e.n® and FERRECARE®.
Emphasis on Recurring Revenue. Modern Beauty has a long
tradition promoting loyalty and repeat customers who generate
consistent recurring revenue, as evidenced by the fact that 73% of
its revenue is from beauty and facial treatment, as opposed to one-
off treatments. During the year to 31 March 2014 sales of new
prepaid beauty packages increased 1% year-on-year (YoY) to
HK$772.2m, showing signs of stability after the “DR Beauty Centre
incident” in late 2012, in which a patient/client died under
treatment. The tragedy caused major disruption to the Hong Kong
beauty care market.
Acquiring Upstream Brand. In July Modern Beauty acquired a
49% stake in the manufacturing and distribution rights of Advanced
Natural®, an Australian beauty care brand which has been
supplying facial products to Modern Beauty for years. Advanced
Natural® has a broad distribution network including Australia,
Europe, Middle East, Southeast Asia and China, and Modern
Beauty aims to leverage its brand reputation and to increase the
product’s penetration in Hong Kong and China. The acquisition
was structured in favourable terms for Modern Beauty: Modern
Beauty will own 49% of the newly formed joint venture (JV) but the
acquisition price will not be paid until three years from now when
certain after-tax profit targets are fulfilled. The intention is to list the
JV separately, according to the announcement.
China Expansion. To capture the beauty care opportunity in
China’s fast-growing middle class, Modern Beauty plans to
aggressively expand its network on the mainland. From
discussions with the company’s senior management we have
learned that the company intends modifying its China strategy,
from opening individual greenfield stores to identifying local
partners and thus broadening their network in multiples. The
company plans to focus on 2nd to 3rd tier cities with a target to
reach at least 50 stores (from 10 stores currently) in two years.
Financial Analysis. Earnings for FY13/3 were affected by the “DR
Beauty Centre incident” causing revenue and gross margin to
suffer. Earnings for FY14 rebounded strongly on margin recovery,
and we particularly like the management’s cost awareness and
August 28, 2014
Source: Bloomberg Consensus Estimates
[Modern Beauty Salon Holdings Limited]
commitment to dividend payout. At a trailing PER of 9.4x,
the valuation does not appear to be expensive compared
to its closest peer, Perfect Shape [1830.HK; Not Rated],
which is on a trailing / forward PER of 20.7x / 19.1x. Near-
term catalysts include 1) A more concrete China
expansion plan; 2) Execution on Advanced Natural®
Key Risks: 1) Regulatory change in Hong Kong’s beauty
care market; 2) Outbreak of medical incident similar to DR
scandal; 3) Weaker-than-expected domestic economy and
retail sector.
0
5
10
15
20
25
0.3
0.4
0.5
0.6
0.7
0.8
Aug13
Sep13
Oct13
Nov13
Dec13
Jan14
Feb14
Mar14
Apr14
May14
Jun14
Jul14
(HK$ million)(HK$)
Turnover (RHS) Price (LHS)
Key Financials
(in HKD m)FY2012/3 FY2012/3 FY2013/3 FY2014/4
Revenue 718.2 756.6 708.1 868.8
Gross Profit 355.3 371.8 281.6 428.1
Gross Margin % 49.5 49.1 39.8 49.3
Net Profit 89.2 82.2 (53.4) 54.8
Net Margin % 12.4 10.9 (7.5) 6.3
EPS (Basic) $0.123 $0.112 -$0.061 $0.063
ROE (%) 33.0 29.7 (25.6) 37.7
Dividend Yield (%) 7.25 12.93 5.08 7.63
PER (x) 4.79 5.27 (9.66) 9.39
PBR (x) 1.52 1.90 3.55 3.55
Capex (m) (22.4) (42.3) (88.6) (60.1)
Free cash flow (m) 170.9 119.1 (53.5) 22.5
7
Figure 1: Revenue Breakdown by Market
Source: Annual Report
Figure 3: Summary Acquisition Terms
Source: HKEX
Beauty & Facial73%
Slimming16%
Spa and Massage
6%
Skincare Products
5%
Figure 2: Products Offering
Source: Annual Report, www.advancednatural.com
Initial consideration: AUD 1.00
Conditional payment: AUD 5,110,200.00 subject to an aggregate after-tax net profit of AUD
3,661,100 for three years ending 30 June 2017
Call Option on premise: AUD 900,000
Conditional payment will be satisfied in cash within 30 days AFTER the listing of the joint venture.
Figure 4: Peers Comparison
Source: Bloobmerg estimates. Yr 0 represents last fiscal year, where Yr+1E and Yr+2E represent forward year 1 and year 2. For Modern Beauty and Perfect Shape, Yr 0
represents FY14/Mar; For Natural Beauty and Bloomage, Yr 0 represents FY13/Dec..
PBR (x)
Company Ticker Price
Market
cap
(US$m)
Yr 0 Yr+1E Yr+2E Yr 0 Yr 0 Yr+1E Yr+2E Yr 0 Yr+1E Yr+2E
MODERN BEAUTY 919 HK equity 0.59 67 9.4 n.a. n.a. 3.6 37.7 n.a. n.a. n.a. n.a. n.a. 1.7
PERFECT SHAPE PR 1830 HK equity 1.74 254 21.0 19.3 13.4 7.3 34.6 29.2 28.5 6.4 8.4 44.4 42.6
NATURAL BEAUTY 157 HK equity 0.54 139 20.7 n.a. n.a. 1.4 7.6 n.a. n.a. (51.7) n.a. n.a. 22.7
BLOOMAGE BIOTE 963 HK equity 15.66 671 39.3 25.6 18.5 7.3 20.1 18.4 21.7 2.8 65.0 38.1 (9.0)
Average 22.6 22.5 16.0 4.9 25.0 23.8 25.1 (14.2) 36.7 41.3 14.5
ROE (%)PER (x)
YTD
Perf (%)
EPS Growth (%yoy)
8
Key Financials
Source: Capital IQ
Income Statement (HKDm) FY2012/3 FY2013/3 FY2014/3 Cash Flow Statement (HKDm) FY2012/3 FY2013/3 FY2014/3
Revenue 758 708 869 Net Income 82 (53) 55
Growth yoy% 5.5% (6.6%) 22.7% Depreciation & Amort. 31 31 44
Gross Profit 372 282 428 Change in Working Capital 48 59 (14)
Growth yoy% 4.6% (24.3%) 52.0% Cash from Ops. 161 36 84
Selling General & Admin Exp. (141) (188) (190) Capital Expenditure (42) (89) (60)
Depreciation & Amortization (31) (31) (44) Sale of Property, Plant, and Equipment 0 0 0
Others Operating Expenses (63) (73) (77) Change in Investing Acitivities (6) 128 (5)
Operating Income 137 (10) 118 Cash from Investing (48) 40 (65)
Growth yoy% 12.3% n.a. n.a. Debt/ Issuance / Repayment 0 0 0
Interest Expense 0.7 1.3 1.6 Equity Issuance / Repurchase 0 0 0 Other Non-Operating Inc. (Exp.) (37) (36) (37) Total Dividends Paid (45) (73) (57)Gain (Loss) On Sale Of Assets - 0 - Others Financing Activities (41) (1) (2) Asset Writedow n 1 (14) - Cash from Financing (86) (74) (59)
Income Tax Expense (19) 5 (27) Foreign Exchange Rate Adj. 2 1 (1)
Minority Int. in Earnings - - - Net Change in Cash 29 3 (40)
Net Income 82 (53) 55
Growth yoy% (7.9%) n.a. n.a.
Balance Sheet (HKDm) FY2012/3 FY2013/3 FY2014/3 Ratios FY2012/3 FY2013/3 FY2014/3
ASSETS Profitability
Cash And Equivalents 484 481 441 Return on Assets % 8.8% (0.6%) 7.5%
Receivables 186 213 207 Return on Capital % 30.4% (2.8%) 48.4%
Inventory 13 19 23 Return on Equity % 29.7% (25.6%) 37.7%
Other Current Assets 46 97 100
Total Current Assets 730 811 771 Margin Analysis
Net Property, Plant & Equipment 76 134 149 Gross Margin % 49.1% 39.8% 49.3%
Deferred Tax Assets, LT 14 24 14 SG&A Margin % 18.7% 26.5% 21.8% Other Long-Term Assets 199 22 20 R&D Margin % 18.0% (1.4%) 13.5%
Total Long Term Assets 289 180 184 Net Income Margin % 10.8% (7.5%) 6.3%
Total Assets 1,019 991 955
Asset Turnover
LIABILITIES & EQUITY Total Asset Turnover 0.8x 0.7x 0.9x
Accounts Payable 1 1 2 Fixed Asset Turnover 11.1x 6.8x 6.1x
Accrued Exp. 0 0 0 Accounts Receivable Turnover 4.8x 3.8x 4.5x
Curr. Port. of LT Debt 3 4 4 Inventory Turnover 31.7x 26.3x 20.6x
Curr. Port. of Cap. Leases 0 0 -
Curr. Income Taxes Payable 18 7 21 Liquidity
Unearned Revenue, Current 649 748 688 Current Ratio 1.0x 1.0x 1.0x
Other Current Liabilities 71 83 89 Quick Ratio 0.9x 0.8x 0.8x
Total Current Liabilities 742 843 805 Avg. Days Sales Out. 75.71 96.15 80.99
Long-Term Debt 5 3 2 Avg. Days Inventory Out. 11.56 13.89 17.68
Capital Leases 0 - - Avg. Days Payable Out. 0.90 0.92 1.39
Def. Tax Liability, Non-Curr. - - 2 Avg. Cash Conversion Cycle 86.37 109.11 97.28
Other Non-Current Liabilities - - - Net Debt to Equity* Net Cash Net Cash Net Cash
Total Liabilities 747 846 810
Common Stock 87 87 87 Growth Over Prior Year
Additional Paid In Capital 290 290 290 Total Revenue 5.5% (6.6%) 22.7%
Retained Earnings 150 54 52 Net Income (7.9%) n.a. n.a.
Comprehensive Inc. and Other (256) (286) (284) Payout Ratio % 55.1% n.a. 39.8%
Minority Interest 0 0 0
Total Equity 272 145 145
Total Liabilities And Equity 1,019 991 955
9
Disclaimer
This research report is not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation or which would subject China Galaxy International Securities (Hong Kong) Co., Limited (“Galaxy International Securities”) and/or its group companies to any registration or licensing requirement within such jurisdiction.
This report (including any information attached) is issued by China Galaxy International Securities (Hong Kong) Co., Limited, one of the subsidiaries of the China Galaxy International Financial Holdings Limited, to the institutional clients from the information sources believed to be reliable, but no repre-sentation or warranty (expressly or implied) is made as to their accuracy, correctness and/or completeness.
This report shall not be construed as an offer, invitation or solicitation to buy or sell any securities of the company(ies) referred to herein. Past perfor-mance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regard-ing future performance. The recipient of this report should understand and comprehend the investment objectives and its related risks, and where necessary consult their own independent financial advisers prior to any investment decision.
Where any part of the information, opinions or estimates contained herein reflects the personal views and opinions of the analyst who prepared this report, such views and opinions may not correspond to the published views or investment decisions of China Galaxy International Financial Holdings Limited and any of its subsidiaries (“China Galaxy International”), directors, officers, agents and employees (“the Relevant Parties”).
All opinions and estimates reflect the judgment of the analyst on the date of this report and are subject to change without notice. China Galaxy Interna-tional and/or the Relevant Parties hereby disclaim any of their liabilities arising from the inaccuracy, incorrectness and incompleteness of this report and its attachment/s and/or any action or omission made in reliance thereof. Accordingly, this report must be read in conjunction with this disclaimer.
Disclosure of Interests
China Galaxy International may have financial interests in relation to the subjected company(ies) the securities in respect of which are reviewed in this report, and such interests aggregate to an amount may equal to or more than 1 % of the subjected company(ies)’ market capitalization.
One or more directors, officers and/or employees of China Galaxy International may be a director or officer of the securities of the company(ies) men-tioned in this report.
China Galaxy International and the Relevant Parties may, to the extent permitted by law, from time to time participate or invest in financing transac-tions with the securities of the company(ies) mentioned in this report, perform services for or solicit business from such company(ies), and/or have a position or holding, or other material interest, or effect transactions, in such securities or options thereon, or other investments related thereto.
China Galaxy International may have served as manager or co-manager of a public offering of securities for, or currently may make a primary market in issues of, any or all of the entities mentioned in this report or may be providing, or have provided within the last 12 months, significant advice or invest-ment services in relation to the investment concerned or a related investment or investment banking services to the company(ies) mentioned in this report.
Furthermore, China Galaxy International may have received compensation for investment banking services from the company(ies) mentioned in this report within the preceding 12 months and may currently seeking investment banking mandate from the subject company(ies).
Analyst Certification
The analyst who is primarily responsible for the content of this report, in whole or in part, certifies that with respect to the securities or issuer covered in this report: (1) all of the views expressed accurately reflect his or her personal views about the subject, securities or issuer; and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific views expressed by the analyst in this report.
Besides, the analyst confirms that neither the analyst nor his/her associates (as defined in the code of conduct issued by The Hong Kong Securities and Futures Commission) (1) have dealt in or traded in the securities covered in this research report within 30 calendar days prior to the date of issue of this report; (2) will deal in or trade in the securities covered in this research report three business days after the date of issue of this report; (3) serve as an officer of any of the Hong Kong-listed companies covered in this report; and (4) have any financial interests in the Hong Kong listed companies cov-ered in this report.
Explanation on Equity Ratings
Copyright Reserved
No part of this material may be reproduced or redistributed without the prior written consent of China Galaxy International Securities (Hong Kong) Co., Limited.
China Galaxy International Securities (Hong Kong) Co. Limited, CE No.AXM459
Room 3501-3507, 35/F, Cosco Tower, Grand Millennium Plaza, 183 Queen’s Road Central, Sheung Wan, Hong Kong. General line: 3698-6888.
BUY share price will increase by >20% within 12 months in absolute terms :
SELL share price will decrease by >20% within 12 months in absolute terms :
HOLD no clear catalyst, and downgraded from BUY pending clearer signal to reinstate BUY or further downgrade to outright SELL :